Owkin ^Investors

Owkin is an AI precision medicine company that focuses on finding the right drug for every patient. They use artificial intelligence to discover and develop better treatments for unmet medical needs, starting with cancer. Owkin uses federated learning, a collaborative AI framework, to unlock valuable insights from siloed datasets while protecting patient privacy. They have raised over $255 million in funding and became a unicorn startup in November 2021. Owkin works with top academic centers to curate and generate deep, multimodal data that is AI ready, and applies AI to subtype patients and identify novel biomarkers for drug discovery and diagnostics.